proteins are molecular switches that control a wide range of biological processes, including signal transduction, protein and membrane trafficking, cytoskeletal and organelle remodelling, and cell growth and proliferation [1] [2] [3] [4] [5] [6] . The G-protein family consists of two major groups: small monomeric GTPases and heterotrimeric G proteins. Both types of G proteins are regulated by a GDP/GTP cycle in which GTP binding activates them 1, 4, [7] [8] [9] . The majority of G proteins are associated with GDP in cells and are considered to be in an inactive form.
. This AKT phosphorylation is controlled by two evolutionarilyrelated kinases, target of rapamycin (TOR) and phosphoinositide 3-kinase (PI3K) 14 . One of the TOR-containing serine/threonine kinase complexes, mTOR complex 2 (mTORC2), phosphorylates AKT directly [16] [17] [18] . This mTORC2-mediated AKT phosphorylation requires the recruitment of AKT to the plasma membrane. Following chemoattractant stimulation, PI3K generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and PIP3 recruits AKT to the plasma membrane through its interaction with a PIP3-binding pleckstrin homology domain of AKT [19] [20] [21] . Ras-GTP interacts directly with PI3K through its Ras-binding domain and this interaction stimulates PIP3 production by PI3K. It has been shown that Ras-GTP also interacts with mTORC2 and stimulates AKT phosphorylation when overexpressed in cells [22] [23] [24] ; however, how Ras regulates the enzymatic activity of mTORC2 against AKT is unknown. To address this critical question, it is essential to determine the function of Ras in mTORC2 activity by separating its function in the PI3K pathway.
In addition, PIP3 stimulates the reorganization of the actin cytoskeleton, probably through the activation of members of the Rho family GTPases, Rac and Rho [25] [26] [27] [28] . Rac controls actin polymerization and network formation at the front of the migrating cells that extend pseudopods. Coordinating with pseudopod extension, Rho regulates actomyosin contraction at the rear end of the cell to move the cytoplasm forward 15 . However, it is unknown whether Rac and Rho have a role in controlling mTORC2 in addition to their known roles downstream of mTORC2 and PI3K signalling.
In the current study, we found that Rho forms a signalling supercomplex with Ras and mTORC2 and activates mTORC2-mediated AKT phosphorylation in vivo and in vitro. A critical regulatory step in this activation mechanism is not GTP binding to Rho, but rather the chemoattractant-stimulated serine phosphorylation of Rho-GDP by glycogen synthase kinase-3 (GSK-3). Our findings provide a principle that controls G proteins through a combination of GDP binding and phosphorylation, and identifies a direct activation mechanism of mTORC2 towards AKT.
Results

RacE-GDP promotes directed cell migration.
In Dictyostlium, all 20 members of the Rho family GTPases have been named Rac ( Supplementary Fig. 1a) . We have previously shown that in Dictyostelium discoideum cells the closest homologue of human RhoA, RacE 29 ( Supplementary Fig. 1b ), is required for directed cell migration towards the chemoattractant cAMP but not for random cell migration (Fig. 1a,b and Supplementary Fig. 2 ) 30, 31 . To investigate the mechanism by which RacE controls chemotaxis, we expressed green fluorescent protein (GFP) fused to wild-type (WT) RacE, GDP-bound RacE T25N or GTP-bound RacE G20V in RacE-knockout Phosphorylated Rho-GDP directly activates mTORC2 kinase towards AKT through dimerization with Ras-GTP to regulate cell migration (KO) cells that normally grow on solid substrates 30, 31 . We examined the chemotactic cell migration towards extracellular cAMP using a microfluidic chamber (Fig. 1a) . Surprisingly, GDP-bound RacE T25N almost completely rescued the migration defects in RacE-KO cells, similar to WT RacE (Fig. 1a,b) , whereas GTP-bound RacE G20V or effector-domain-defective RacE T43A failed to do so. Metabolic labelling using P 32 showed that WT RacE and RacE T25N are mainly associated with GDP, whereas RacE G20V is predominantly bound to GTP (Fig. 1c-e) . These data suggest that RacE-GDP mediates directed cell migration.
RacE-GDP interacts with mTORC2. Chemoattractants stimulate signal transduction pathways involving mTORC2 and AKT via GPCRs in Dictyostelium cells and human neutrophils 15, 18, [32] [33] [34] [35] . Using proteomic analysis of RacE-binding proteins, we identified two subunits of mTORC2, Tor (TOR homologue) and PiaA (Rictor homologue; Supplementary Figs. 1c, 3 and Supplementary Tables 1,  2) 15, 16, 36, 37 . Subsequent co-immunoprecipitation assays showed that both Tor and PiaA specifically co-precipitated WT RacE or GDPbound RacE T25N but not GTP-bound RacE G20V or effector-domaindefective RacE T43A (Fig. 2a,b) . As described above, WT RacE is primarily GDP-bound; therefore, RacE-GDP specifically interacts with mTORC2 and this interaction requires the effector domain. Unlike RacE, a homologue of human Rac1, Dictyostelium Rac1A ( Supplementary Fig. 1b ) failed to interact with mTORC2 regardless of its guanine-nucleotide-binding status (Fig. 2c) . To determine whether GDP-dependent interactions between Rho and mTORC2 are conserved in humans, we performed co-immunoprecipitation of yellow fluorescent protein (YFP)-RhoA and YFP-Rac1 with mTORC1 and -2 in human embryonic kidney (HEK) 293T cells. GDP-bound RhoA T19N bound most strongly to the two mTORC2 subunits, Tor and Rictor, but did not bind the mTORC1 subunit Raptor (Fig. 2d,e) .
mTORC2-mediated AKT phosphorylation requires RacE-GDP in cells.
To determine the function of RacE in mTORC2 signalling in cells, we first examined the impact of RacE loss on the phosphorylation of AKT, a major substrate of mTORC2 15, 19 . Two AKT homologues (PkbA and PkbR1) are phosphorylated by mTORC2 in the hydrophobic motif and by PDK in the activation loop ( Fig. 2f and Supplementary Fig. 4 ) 11, 19, 38 . Both sites were transiently phosphorylated in response to GPCR activation by cAMP in WT cells but not in cells lacking the Rictor homologue PiaA (Fig. 2g,h ), as previously reported 39 . Similarly to observations in PiaA-KO cells, chemoattractant-induced AKT phosphorylation was greatly decreased in G20V or effector-domain-defective RacE T43A for 60 min in a microfluidic chamber (a). Scale bar, 100 µm. Chemotaxis efficiency was quantified by measuring the number of cells that moved towards a higher concentration of cAMP (observation window; b). The chemotaxis efficiency in RacE-KO cells expressing WT RacE (KO + RacE) was set as 100% (n = 4 independent experiments). P values are shown for the comparisons to KO + RacE. c-e, Guanine-nucleotide binding to RacE. Differentiated Dictyostelium cells carrying GFP, GFP-RacE, GFP-RacE T25N or GFP-RacE G20V were metabolically labelled using P 32 for 1 h. c, GFP fusion proteins were immunopurified using GFP-Trap beads and analysed using SDS-PAGE and Coomassie Brilliant Blue (CBB) staining. d, Bound guanine nucleotides were analysed by thin-layer chromatography and phosphoimaging. e, Quantification of GDP (left) and GTP (right; n = 5 independent experiments for GFP-RacE and GFP-RacE G20V and n = 4 independent experiments for GFP-RacE T25N ) P values are shown for comparison of GFP-RacE with others. Data in b,e are shown as the average ± s.d. Significance was calculated using analysis of variance (ANOVA) with a Tukey's post-hoc test.
Fig. 2 |
Race-GDP specifically interacts with mTORC2. a, Dictyostelium cell lysates carrying GFP fused to the indicated forms of RacE were incubated with cell lysates carrying FLAG-Tor and subjected to immunoprecipitation with GFP-Trap (left). Quantification of the interactions is shown (right). The band intensity of FLAG-Tor in the immunoprecipitates of cells expressing WT RacE was set as 100% (n = 6, 6, 6 and 3 independent experiments for RacE, RacE T25N , RacE G20V and RacE T43A , respectively). P values are shown for the comparisons to RacE. b, Dictyostelium cell lysates carrying the indicated forms of GFP-RacE were subjected to immunoprecipitation with GFP-Trap (left) to analyse its association with endogenous PiaA (right). The band intensity of PiaA in the immunoprecipitates of the cells expressing WT RacE was set as 100% (n = 3 independent experiments). P values are shown for the comparisons to RacE. c, Dictyostelium cell lysates carrying GFP fused to the indicated forms of Rac1A and RacE were incubated with cell lysates carrying FLAG-Tor and subjected to immunoprecipitation with GFP-Trap. The experiment was repeated independently three times with similar results. d, HEK293T cells were transfected with YFP fused to the indicated constructs of human Rac1 and RhoA, and subjected to immunoprecipitation using GFP-Trap (left). The band intensities of Tor and Rictor in the immunoprecipitates of the cells expressing WT RhoA was set as 100% (right; n = 3 and n = 4 independent experiments for Tor (top) and Rictor (bottom), respectively). P values are shown for the comparisons to YFP-RhoA. e, Summary of the data in a-d. f, AKTs are phosphorylated in the hydrophobic motif by mTORC2 and in the activation loop by PDK. g,h, WT, RacE-KO and PiaA-KO Dictyostelium cells were stimulated with cAMP (1 µM; n = 3 independent experiments). The total quantities of two AKT homologues (PkbR1 and PkbA) and their phosphorylation (hydrophobic motif in red and activation loop in green) were analysed by immunoblotting (g). PVDF membranes were stained with CBB as a loading control (g, bottom). h, Quantification of the band intensity of phosphorylated AKTs. WT cells at 30 s were set at 100%. Data in a,b,d,h are shown as the average ± s.d. Significance in a,b,d was calculated using ANOVA with a Tukey's post-hoc test. IP, immunoprecipitation. RacE-KO cells (Fig. 2g,h ). The total quantities of endogenous PkbR1 and PkbA did not change in either PiaA-KO or RacE-KO cells in the presence or absence of chemoattractant simulation (Fig. 2g) . Second, we expressed WT RacE and various RacE mutants in RacE-KO cells, and then stimulated these cells with cAMP. Intriguingly, WT RacE and GDP-bound RacE T25N , but not GTP-bound RacE G20V or effector-domain-defective RacE T43A , restored mTORC2-mediated AKT phosphorylation in response to chemoattractants (Fig. 3a-d) . It has been shown that a mutation (G17V) in human RhoA, which dissociates GTP from RhoA, is a prevalent driver mutation in T-cell lymphoma 40, 41 ; in cells carrying RhoA G17V , AKT phosphorylation is increased. To test whether an equivalent mutation promotes AKT phosphorylation in Dictyostelium cells, we expressed RacE G23V in WT and RacE-KO cells and found that RacE G23V increases the phosphorylation of PkbR1 and PkbA in both cell types (Fig. 3c-f) . The expression levels of the GFP-RacE proteins were comparable in cells ( Supplementary Fig. 5 ). Third, the mTORC2 inhibitor PP242 completely blocked cAMP-induced AKT phosphorylation in WT and RacE-KO cells expressing WT RacE (Fig. 3g,h ). Fourth, AKT phosphorylation requires RasC and is increased by ectopic expression of GTP-bound RasC Q62L
23
. We found that RacE is necessary for this RasC Q62L -stimulated AKT phosphorylation (Fig. 3i,j) . Fifth, consistent with the function of RacE-GDP and RasC-GTP in chemotactic signalling, metabolic labelling with P 32 showed that GDP binding to RacE and GTP binding to RasC significantly increased in response to cAMP ( Supplementary Fig. 6 ).
GSK-3 phosphorylates RacE at S192 in response to chemotactic stimulation. Previous phosphoproteomics have suggested that chemoattractant stimulation induces RacE phosphorylation at S192 in Dictyostelium cells 42 . Using antibodies raised to S192 phosphoRacE, we found that RacE indeed undergoes transient phosphorylation following chemoattractant stimulation (Fig. 4a) . To confirm the specificity of our S192 phospho-RacE antibodies, we expressed GFPRacE, phospho-defective GFP-RacE S192A and phospho-mimetic GFP-RacE S192D in WT cells and stimulated these cells with cAMP. We found that GFP-RacE was transiently phosphorylated at S192, similarly to endogenous RacE (Fig. 4b) . In contrast, phospho-defective GFP-RacE S192A was not detected by anti-phospho-RacE(S192) antibodies (Fig. 4b) . As a positive control, phospho-mimetic GFPRacE S192D was detected by anti-phospho-RacE(S192) antibodies even in the absence of chemoattractant stimulation.
To identify the protein kinase that phosphorylates RacE in response to chemoattractants, we first analysed the amino acid sequence around S192 and found a GSK-3-substrate motif (Fig. 4c) . A modelled structure of RacE based on human RhoA suggested that S192 is located in a C-terminal unstructured loop of RacE (Fig. 4d) . To determine whether S192 phosphorylation depends on GSK-3 in cells, we pretreated Dictyostelium cells with LY2090314 and lithium, two structurally-distinct inhibitors specific to GSK-3, and stimulated these cells with cAMP. Immunoblotting showed that the chemoattractant-induced S192 phosphorylation of RacE was completely blocked (Fig. 4e,f) . Conversely, other inhibitors of PI3K (LY294002) and mTORC2 (PP242) did not inhibit this RacE phosphorylation (Fig. 4g) . We also found no inhibition of the RacE phosphorylation in WT cells treated with an AKT inhibitor (afuresertib; Fig. 4h ) or cells lacking either PkbA or PkbR1 (Fig. 4i) . To investigate whether GSK-3 directly phosphorylates RacE at S192, we incubated purified human GSK-3β with purified FLAG-RacE, FLAG-RacE T25N (GDP-bound) or FLAG-RacE S192A (phosphodefective). We found that GSK-3β phosphorylates FLAG-RacE and FLAG-RacE T25N , but not FLAG-RacE S192A , on S192 in vitro (Fig. 4j) . This in vitro phosphorylation of RacE by purified GSK-3β was inhibited by the GSK-3 inhibitor LY2090314 (Fig. 4k) . These data suggest that GSK-3 directly phosphorylates S192 in RacE in response to chemotactic stimulation (Fig. 4l) .
Chemoattractant-induced phosphorylation of RacE-GDP at S192 controls mTORC2-mediated AKT phosphorylation and directed cell migration. When ectopically expressed in RacE-KO cells, phospho-defective RacE S192A did not induce AKT phosphorylation in response to chemoattractant stimulation (Fig. 5a,b) . Conversely, phospho-mimetic RacE S192D increased AKT phosphorylation even without stimulation (0 s in Fig. 5a ,b). The expression levels of these GFP-RacE proteins were comparable in cells ( Supplementary Fig. 5 ). GTP-bound RacE G20V remained inactive even when combined with the S192D mutation (Fig. 5c,d ), suggesting that the phosphorylation of RacE-GDP at S192 is crucial for the activation of mTORC2.
Both the phospho-mimetic mutants RacE S192D and GDP-bound RacE T25N,S192D rescued defects in directed cell migration towards cAMP in RacE-KO cells (Fig. 5e,f) . In contrast, the phospho-defective RacE S192A mutation blocked the ability of WT RacE and RacE T25N to reverse the cell-migration defect (Fig. 5e,f) . Furthermore, the mTORC2inhibitor PP242 blocked the cell migration of RacE-KO cells expressing WT RacE or phospho-mimetic RacE S192D , whereas LY2090314 only blocked the migration of RacE-KO cells expressing WT RacE (Fig. 5g,h ). Therefore, chemoattractant stimulation induces the GSK-3-mediated S192 phosphorylation of RacE-GDP to activate mTORC2-mediated AKT phosphorylation in directed cell migration.
Reconstitution of GDP-bound RacE-regulated mTORC2 activation in vitro.
To elucidate the molecular mechanism by which RacE-GDP regulates mTORC2, we reconstituted the chemoattractant-induced activation of mTORC2 using proteins purified from Dictyostelium cells (Fig. 6 ). To purify mTORC2 as an active kinase complex, we immunopurified FLAG-Tor under low-salt conditions in the presence of the detergent CHAPS, as described 43, 44 ( Supplementary Fig. 7a -c). We used inactive human AKT as a substrate and detected its phosphorylation using anti-phospho-AKT antibodies (S473) 43, 44 . AKT was robustly phosphorylated when incubated with mTORC2, chemoattractant-stimulated RacE and GTP-bound RasC Q62L (Fig. 6a, lane 3) . We omitted ATP, RacE, RasC and mTOR2 or used kinase-dead Tor D2146A for the negative controls (Fig. 6a , lanes 2 and 4-8).
The Tor kinase forms mTORC2 with other subunits, including Rictor, mLst8 and mSin1 ( Supplementary Fig. 1c ) 16, 24, 37 . To define the minimum set of subunits required for mTORC2 activation, we purified mTORC2 from WT cells or cells lacking each subunit (Rictor/ PiaA-KO, Lst8-KO or mSin1/Rip3-KO) using FLAG-Tor under CHAPS-containing, low-salt conditions. Although mTORC2 purified from WT cells phosphorylated AKT, mTORC2 purified from any of these KO cells failed to do so (Fig. 6b , lanes 1, 2, 5 and 8). We then added high-salt-washed purified FLAG-Lst8 or FLAG-PiaA to the purified mTORC2 ( Fig. 6b and Supplementary Fig. 7f ). FLAG-Lst8 restored AKT phosphorylation when added to mTORC2 purified from Lst8-KO cells but not Rip3-KO or PiaA-KO cells (Fig. 6b , lanes 4, 7 and 10). Surprisingly, FLAG-PiaA restored AKT phosphorylation when added to mTORC2 purified from not just PiaA-KO cells but also Rip3-KO cells (Fig. 6b , lanes 3 and 6). PiaA was dissociated from mTORC2 in the absence of Rip3, as immunoblotting showed that endogenous PiaA did not co-purify with FLAG-Tor in Rip3-KO cells (Fig. 6b, lane 2) . Whole cell lysates from WT and Rip3-KO cells contained similar quantities of PiaA ( Supplementary Fig. 7d ). These data suggest that PiaA and Lst8 are essential subunits of mTORC2 for AKT phosphorylation, whereas the mSIN1 homologue Rip3 stabilizes the interactions between PiaA and mTORC2.
To further test this idea, we purified FLAG-Tor under high-salt conditions, which failed to phosphorylate AKT (Fig. 6c, lane 2) . We added FLAG-PiaA and FLAG-Lst8 back to the FLAG-Tor. AKT phosphorylation was restored only when both subunits were added together but not individually (Fig. 6c, lanes 3-5) . Therefore, the mTORC2 components Tor, PiaA and Lst8 are sufficient to catalyse GDP-bound RacE-promoted AKT phosphorylation. S192 phosphorylated RacE-GDP activates mTORC2-mediated AKT phosphorylation in vitro. Using this reconstitution system, we tested the effect of the guanine-nucleotide-binding status of RacE and RasC on mTORC2 activation in vitro. First, we removed guanine nucleotides from purified FLAG-RacE using EDTA and found that mTORC2 activation was completely blocked (Fig. 6d,  lane 3) . Second, no mTORC2 activation was observed when FLAGRacE was loaded with the non-hydrolyzable GTP analogue GTPγS (Fig. 6d, lane 4) . The subsequent replacement of GTPγS with GDP restored the ability of RacE to activate mTORC2 (Fig. 6d, lane 5) . These guanine-nucleotide-switching experiments ruled out the possibility that other proteins, such as guanine-nucleotide exchange factors that might associate with GDP-bound RacE T25N , contribute to mTORC2 activation. Third, WT RacE and GDP-bound RacE T25N , but not GTP-bound RacE G20V , activated mTORC2 (Fig. 6e) . Fourth, GTP-bound RasC Q62L , but not GDP-bound RasC S18N , activated mTORC2 (Fig. 6f, lanes 1, 2, 5 and 6 ). Another Ras homologue, RasG 12, 22 , did not activate mTORC2 regardless of its guanine-nucleotide-binding status (Fig. 6f, lane 3 Fig. 4 | GSK-3 phosphorylates Race at S192 in response to chemoattractant. a, WT and RacE-KO cells were stimulated with cAMP (1 µM). The total amounts of RacE and its phosphorylation at S192 were analysed by immunoblotting with antibodies to RacE and phospho-RacE(S192). b, WT cells expressing GFP fused to WT RacE, phospho-defective RacE S192A or phospho-mimetic RacE S192D were stimulated with cAMP. The whole cell lysates prepared at the indicated time points were analysed by immunoblotting with antibodies to RacE and phospho-RacE(S192). c, Amino acid sequence in the vicinity of the phosphorylation site (S192; red) of RacE. The consensus motif for GSK-3 phosphorylation-a cluster of (S/TXXXS/T)-is underlined in blue. The phosphopeptide used to raise anti-phospho-RacE(S192) is highlighted in red. d, Location of S192 in a modelled three-dimensional RacE structure. e-h, WT cells were treated with GSK-3 (e, 250 nM LY2090314 and f, 10 mM lithium), PI3K (g, 250 µM LY294002), mTORC2 (g, 0.5 µM PP242) and AKT (h, 5 µM afuresertib) inhibitors for 10 min. The cells were then stimulated with cAMP for the indicated times. The whole cell lysates were analysed by immunoblotting with antibodies to RacE and phospho-RacE(S192). i, WT cells and cells lacking AKT (PkbA-KO or PkbR1-KO) were stimulated with cAMP for 30 s. The whole cell lysates were analysed by immunoblotting with the indicated antibodies. j, Purified human GSK-3β was incubated with purified WT, RacE T25N or phospho-defective RacE S192A for 15 min. S192 phosphorylation of RacE was tested by immunoblotting. k, WT or GDP-bound RacE T25N was mixed with GSK-3β in the presence or absence of LY2090314 (10 nM) and examined for S192 phosphorylation by immunoblotting. l, Summary of the data in a-c,e-k. The experiments in a,b,e-k were repeated independently three times with similar results.
Chemoattractant stimulation of Dictyostelium cells before the purification of FLAG-RacE was required for the reconstitution of mTORC2 activation (Fig. 6d, lanes 1 and 2 and Fig. 6e, lanes 1-4) . This chemoattractant stimulation was no longer necessary when phospho-mimetic GDP-bound RacE T25N,S192D was used (Fig. 6g, lanes  1 and 5) . Conversely, phospho-defective GDP-bound RacE T25N,S192A failed to activate mTORC2-mediated AKT phosphorylation irrespective of the chemoattractant stimulation (Fig. 6g, lanes 3 and 4) . +RacE S192A +RacE S192D +RacE +RacE T25N,S192D +RacE S192D +RacE +PP242 +LY2090314 +RacE +RacE S192A +RacE S192D
Size (kDa)  0  30  60  120  180  0  30  60  120  180  0  30  60  120  180  0  30  60  120  180  0  30  60  120 . WT cells at 30 s were set at 100%. e-h, Directed cell migration towards cAMP was analysed for RacE-KO cells carrying different GFP-RacE constructs in a microfluidic chamber in with or without inhibitors to mTORC2 (0.5 µM PP242) or GSK-3 (250 nM LY2090314). Scale bars, 100 µm. The chemotaxis efficiency was quantified in f,h for e,g, respectively. The chemotaxis efficiency of RacE-KO cells expressing WT RacE was set as 100%. Data are shown as the average ± s.d. Significance was calculated using ANOVA with a Tukey's post-hoc test. P values are shown for comparison to RacE in f (n = 4 independent experiments) and as indicated in g (n = 6, 3, 3, 6, 3 and 3 independent experiments for untreated RacE, untreated RacE S192D , PP242-treated RacE, PP242-treated RacE S192D , LY2090314-treated RacE and LY2090314-treated RacE S192D , respectively). Purified proteins were used to reconstitute mTORC2-mediated AKT phosphorylation. FLAG-RacE, FLAG-RasC/G and mTORC2 (FLAG-Tor, -PiaA and -Lst8) were purified from Dictyostelium cells. +cAMP, cells were stimulated by the chemoattractant for 30 s before the purification of FLAG-RacE. Purified proteins were mixed in the presence or absence of ATP and human inactive AKT for 5 min at room temperature. AKT phosphorylation was analysed by immunoblotting using anti-phospho-AKT(S473) antibodies. a, mTORC2 phosphorylates AKT in the presence of RacE and RasC. KD, kinase dead. b,c, Activation of mTORC2 requires PiaA and Lst8 but not Rip3. FLAG-PiaA and FLAG-Lst8 were added to FLAG-Tor purified from the indicated KO cell lines in b. FLAG-PiaA and/or FLAG-Lst8 were incubated with high-salt-washed FLAG-Tor in c. d, Activation of mTORC2 requires RacE-GDP. Purified RacE was incubated with EDTA (25 mM), GTPγS (0.5 mM) or GTPγS followed by GDP (2.5 mM; GTPγS → GDP) before reconstitution. e, WT RacE and GDP-bound RacE T25N , but not GTP-bound RacE G20V , activates mTORC2 after stimulation with chemoattractant. f, Activation of mTORC2 needs RasC-GTP but not RasG-GTP. g, RacE phosphorylation controls mTORC2 activation. The S192D mutation in GDP-bound RacE T25N activates mTORC2 without chemoattractant stimulation, whereas the phospho-defective RacE S192A mutation blocks it. h, Activation of mTORC2 requires RasC-GTP. Purified RasC was incubated with EDTA followed by either GTPγS or GDP before reconstitution. i, Summary of the data in a-h. j, RacE G23V -GDP activates mTORC2. Purified RacE T25N and RacE G23V were incubated with EDTA followed by GTPγS or GDP before reconstitution. The experiments in a-h,j were repeated independently three times with similar results.
We also found that RasC must be in a GTP-bound form to stimulate mTORC2 in guanine-nucleotide-switching experiments (Fig. 6h) . Together, these data show that chemoattractant-stimulated phosphorylation of RacE-GDP at S192 together with RasC-GTP directly activate mTORC2-mediated AKT phosphorylation (Fig. 6i) . RacE G23V is equivalent to the cancer driver mutant RhoA G17V (Fig. 3c-f) . The G17V mutation dissociates GTP from RhoA 40, 41, 45, 46 ; however, it is unknown whether RhoA G17V is present in a guaninenucleotide-free or GDP-bound form. Using our reconstitution system, we tested the effect of the guanine-nucleotide-binding status of RacE G23V on mTORC2 activation. Similar to GDP-bound FLAGRacE T25N , purified FLAG-RacE G23V stimulated mTORC2-mediated AKT phosphorylation (Fig. 6j, lanes 1 and 2) . When we treated FLAG-RacE G23V with EDTA, which removes guanine nucleotides that are potentially associated, this activity was lost (Fig. 6j, lane 4) . Subsequent incubation of FLAG-RacE G23V with GDP, but not GTPγS, restored its ability to activate mTORC2 (Fig. 6j, lanes 6 and 8) . Therefore, RacE G23V activates mTORC2 in a GDP-bound form. S192 phosphorylation of RacE-GDP assembles the RacE-RasCmTORC2 supercomplex. To understand the biochemical basis of this phospho-mediated activation, we purified GDP-bound FLAGRacE T25N from Dictyostelium cells under high-salt conditions after chemoattractant stimulation and tested its interaction with purified FLAG-RasC proteins ( Fig. 7a and Supplementary Fig. 7e ). The chemoattractant stimulation enabled GDP-bound RacE T25N to interact specifically with GTP-bound RasC Q62L but not GDP-bound RasC S18N (Fig. 7a, lanes 2 and 8) . The phospho-defective RacE S192A mutation abolished this chemoattractant-induced interaction of RacE-GDP with RasC-GTP (Fig. 7a, lanes 2 and 4) . Conversely, the phosphomimetic S192D mutation bypassed the requirement for chemoattractant stimulation (Fig. 7a, lanes 1 and 5) . GTP-bound RacE G20V did not interact with either RasC-GTP or RasC-GDP, even after chemoattractant stimulation (Fig. 7b, lanes 3 and 4) . Therefore, S192 phosphorylation of RacE-GDP enables its interaction with RasC-GTP.
Phosphorylated RacE also binds Tor. GDP-bound RacE T25N purified after chemotactic stimulation bound FLAG-Tor that had been purified under high-salt conditions (Fig. 7c, lane 5) . Although it has been shown that recombinant GTP-loaded RasC binds the kinase domain of Tor purified from Escherichia coli 22 , RasC or RasG failed to bind Tor in our binding assay, regardless of their guanine-nucleotide binding status (Fig. 7c, lanes 1-4) . Interactions of phosphorylated RacE with Tor require its GDP binding but are independent of RasC (Fig. 7d) . Furthermore, chemoattractant-stimulated GDPbound RacE bridges GTP-bound RasC and Tor (Fig. 7e) . Finally, interactions between RacE and RasC or Tor were sensitive to the pretreatment of chemoattractant-stimulated cells with LY2090314 before the purification of RacE (Fig. 7f,g) ; the S192D mutation overcame this inhibition effect (Fig. 7f,g, lanes 5 and 6) . These data suggest that chemoattractant-induced S192 phosphorylation of GDP-bound RacE assembles the RacE-RasC-mTORC2 supercomplex that phosphorylates AKT (Fig. 7h) .
Discussion
In this study, we discovered an unforeseen mechanism by which the phosphorylation of GDP-bound Rho GTPase activates mTORC2 signalling in GPCR-mediated directed cell migration. We propose that phosphorylated Rho-GDP forms the super signalling complex with Ras-GTP and mTORC2 (Fig. 7h) . Our findings change the current view that switching guanine nucleotides from GDP to GTP activates G proteins 1, 4, [7] [8] [9] . Because the majority of the G proteins are in a GDP-bound form, this mechanism for G-protein regulation broadens the understanding of intracellular signal transduction mediated by one of the largest protein families that control many biological processes substantially. Our findings also demonstrate a role for Rho as an upstream component that connects GPCR activation to mTORC2 to initiate a signalling cascade. This role of Rho revises the prevailing model that Rho is a downstream regulator that couples signalling events to the remodelling of the actin cytoskeleton. In our previous studies, we identified a potential GTPaseactivating protein (GflB) and guanine-nucleotide exchange factor (GxcT) for RacE 30, 31 . As both GflB and GxcT contribute to directed cell migration, it would be important to decipher how they regulate the function of phosphorylated RacE-GDP in mTORC2 activation in future studies.
We propose that phosphorylated RacE-GDP simultaneously binds both RasC-GTP and mTORC2 (Fig. 7h) . In this supercomplex, RacE probably binds RasC and mTORC2 through distinct regions. We speculate that Tor binds the effector domain of RacE. On the other hand, RasC might interact with RacE in a manner similar to human KRas dimers [47] [48] [49] . Our data show that the activation mechanism for mTORC2 by small GTPases is distinct from that for mTORC1. The localization of mTORC1 is regulated by small GTPases, Rags. A Rag dimer formed by RagA/B-GDP and RagC/D-GTP is anchored to the lysosomal membrane through the regulator protein complex 16 . In response to increased levels of amino acids, these GTPases switch guanine nucleotides and become a RagA/B-GTP and RagC/D-GDP dimer. This dimer associates with Raptor and localizes mTORC1 to lysosomes. On the surface of lysosomes, the kinase activity of mTORC1 is activated by interactions with GTP-bound Rheb, a Ras-related GTPase. Similarly to the Rag dimers, RacE and RasC form a dimer in the GDP-and GTP-bound forms, respectively. However, in contrast to the Rag dimers, RacERasC dimers directly stimulate the enzymatic activity of mTORC2.
It has been shown that GSK-3 regulates chemotaxis and differentiation in Dictyostelium cells 50, 51 ; however, the role of GSK-3 in mTORC2-AKT signalling has been controversial: one group showed that GSK-3-KO cells increase this signalling in response to chemotactic stimulation 52, 53 , whereas another group reported the opposite effect 54 . Significantly extending the latter findings, our current work reveals that GSK-3 directly phosphorylates the C-terminus of RacE at S192 following cAMP stimulation to promote the assembly of the mTORC2 supercomplex that phosphorylates AKTs.
Our in vitro system identified a minimum set of proteins that reconstitute chemoattractant-stimulated mTORC2 activation. In this system, the kinase Tor together with the Rictor homologues PiaA and LST8, are the necessary mTORC2 subunits and sufficient for activation. The mSin1 homologue Rip3 is important for the stabilization of the interactions between Tor and PiaA in cells, but is not essential for the enzymatic activity regulated by RacE and RasC. Providing supporting to our findings, previous studies using mammalian cells have shown that mSin1 is important for the formation of mTORC2 24 . In addition, mSin1 contains a lipid-binding pleckstrin homology domain and is necessary for the recruitment of mTORC2 to the plasma membrane 24 . A mutation (G17V) that releases GTP from human RhoA is a prevalent driver mutation in T-cell lymphoma 40, 41 . AKT phosphorylation, the reorganization of the actin cytoskeleton and cell migration are increased in cells carrying RhoA G17V or a GDPbound RhoA T19N . These findings have been explained by the sequestration of guanine-nucleotide-exchange factors through stabilized interactions with the RhoA G17V and RhoA T19N mutant proteins. In contrast to this model, we found that RacE G23V and RacE T25N -the RhoA G17V and RhoA T19N counterparts in Dictyostelium, respectively-induce AKT phosphorylation in cells and directly activate mTORC2-mediated AKT phosphorylation in a GDP-bound form in vitro. In light of our findings in the Dictyostelium Rho GTPase, it would be important to test whether the unique cancer-associated RhoA mutation (G17V) is GDP-bound in cancer cells, activates the kinase activity of mTORC2 towards AKT, and thereby promotes cancer cell proliferation and metastasis. The indicated GFP-RacE proteins were purified from Dictyostelium cells with or without 1 µM cAMP stimulation for 30 s. FLAG-RasC proteins were purified without cAMP stimulation. GFP-RacE was incubated with FLAGRasC and pulled down using GFP-Trap. The pellet fraction was analysed by immunoblotting using antibodies to GFP and FLAG. c, GFP-RacE, GFP-RasC and GFP-RasG were incubated with FLAG-Tor, which was purified under high-salt conditions and pulled down with GFP-Trap. The pellet fraction was analysed by immunoblotting using antibodies to GFP and FLAG. d, GFP fused to GDP-bound RacE T25N or GTP-bound RacE G20V were purified from Dictyostelium cells under high-salt conditions after stimulation with cAMP. These GFP fusion proteins were incubated with high-salt-washed FLAG-Tor and/or FLAG-RasC proteins. GFP-RacE was pulled down with GFP-Trap and the pellet fractions were analysed by immunoblotting. e, RacE forms a complex with Tor and RasC. The indicated proteins were purified under high-salt conditions and mixed for 15 min at room temperature. GFP-RasC proteins were pulled down with GFPTrap and the pellet fraction was analysed by immunoblotting. f,g, Different GFP-RacE proteins were purified from Dictyostelium cells with or without 1 µM cAMP stimulation for 30 s in the presence or absence of LY2090314 (250 nM). GFP-RacE was incubated with FLAG-RasC (f) or FLAG-Tor (g) and pulled down using GFP-Trap. The pellet fraction was analysed by immunoblotting using antibodies to GFP and FLAG. h, Model of the GPCR-mediated mTORC2-AKT signalling. In response to GPCR activation by chemoattractant, Rho-GDP becomes phosphorylated by GSK-3 and assembles the super signalling complex with Ras-GTP and mTORC2 to promote AKT phosphorylation. The experiments in a-g were repeated independently three times with similar results.
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Methods
Cells and plasmids. Disruption of the RacE, PiaA, Rip3 and Lst8 genes by homologous recombination using the blasticidin resistance cassette in D. discoideum cells was done as previously described 30, 36, 38, 55 . WT, PiaA-KO, Rip3-KO and Lst8-KO Dictyostelium cells were cultured in HL5 medium (1% protease peptone, 1% glucose, 0.5% yeast extract, 2.5 mM Na 2 HPO 4 and 2.5 mM KH 2 PO 4 (pH 6.5)) on a rotary shaker at 200 r.p.m. and 22 °C. RacE-KO cells were cultured in HL5 medium in Petri dishes and shaken for 1 d before use in experiments 30 . Plasmids were introduced into Dictyostelium cells by electroporation and stable cell lines carrying the plasmids were selected with G418 or hygromycin 30 . To induce cell differentiation, cells growing exponentially were washed with development buffer (DB; 2 mM MgSO 4 , 0.2 mM CaCl 2 , 5 mM Na 2 HPO 4 and 5 mM KH 2 PO 4 (pH 6.5)), resuspended at 2 × 10 7 cells ml −1
, starved for 1 h and shaken with 100 nM cAMP pulses at intervals of 6 min for 4 h. To induce FLAG-RasC/G expression, 200 µg ml −1 doxycycline hyclate was included in the DB during differentiation. HEK293T cells were maintained in DMEM medium containing 10% fetal bovine serum and were transiently transfected with a peYFP-C1 plasmid carrying WT or mutant versions of human RhoA or Rac1 using Lipofectamine 3000 (Life Technologies, L3000015) according to the manufacturer's protocol. The transfected cells were cultured overnight before analysis. The plasmids are listed in Supplementary Table 3 .
Directed cell migration assay. Chemotactic migration towards cAMP was analysed using a microfluidic chamber, as reported 56 with some modifications. To generate a stable cAMP gradient, 1 µM cAMP, 500 µM SQ22536 (Sigma-Aldrich, S153), 2 mM MgSO 4 , 5 mM Na 2 HPO 4 and 5 mM KH 2 PO 4 (pH 6.5) was loaded into the chamber. Next, differentiated Dictyostelium cells were resuspended in 500 µM SQ22536, 2 mM MgSO 4 , 5 mM Na 2 HPO 4 and 5 mM KH 2 PO 4 (pH 6.5) at 1 × 10 5 cells ml
. Five-hundred cells were loaded into the opposite side of the microfluidic chamber. Images of cells were recorded for 60 min using an Axio Vision inverted microscope (Zeiss) with a ×10 objective. The number of cells that moved towards a higher concentration of cAMP was quantified.
Identification of RacE-binding proteins. Dictyostelium cells expressing GFP-RacE proteins were lysed in lysis buffer (150 mM NaCl, 0.5% Triton X-100, 1 mM NaF, 0.5 mM Na 3 VO 4 , 1 mM dithiothreitol, 10% glycerol, 25 mM Tris-HCl (pH 7.5) and protease inhibitor cocktail (Roche, cat. no. 4693159001)) and incubated with GFP-Trap magnetic beads (ChromoTek, gtma-200) for 4 h at 4 °C. The beads were washed and the bound fractions were analysed using mass spectrometry at the Johns Hopkins Mass Spectrometry and Proteomics Facility ( Supplementary Fig. 3 and Supplementary Tables 1, 2 ). . The cells were incubated with 500 µCi ml −1 P 32 for 40 min at 22 °C and then further incubated in the presence of 2 mM caffeine for 20 min 57 . The cells were washed twice in ice-cold DB-MES, resuspended at 1 × 10 8 cells ml −1 and lysed in an equal volume of ice-cold 2×lysis buffer (2% NP-40, 300 mM NaCl, 20 mM MES (pH 6.5), protease inhibitor cocktail and phosphatase inhibitors (Sigma, P5726)) on ice for 10 min. After clarification by centrifugation at 4 °C, 1 ml of the cell lysates was incubated with 20 µl of GFP-Trap agarose beads (ChromoTek, gta-200) or anti-FLAG agarose M2 beads (Sigma, A2220) at 4 °C for 1 h with gentle agitation. After washing twice with 1×lysis buffer, the beads were incubated with 40 µl elution solution (1 mM GTP, 0.2% SDS, 5 mM dithiothreitol and 2 mM EDTA (pH 8.0)) at 65 °C for 5 min to elute the guanine nucleotides. The samples were spotted on polyethylenimine cellulose thin-layer-chromatography plates and developed in 0.75 M KH 2 PO 4 (pH 3.4) 58 . The thin-layer-chromatography plates were exposed to phosphoimaging screens and scanned using a Bio-Rad PharosFX Plus molecular imager; the images were analysed with NIH ImageJ. Proteins bound to the beads were eluted with SDS-PAGE sample buffer and analysed by SDS-PAGE and CBB staining.
Immunoprecipitation. Protein-protein interactions were assayed as performed previously 31 with some modifications. To prepare the Dictyostelium cell lysates, cells carrying different plasmids were differentiated in DB and incubated with 2 mM caffeine at 22 °C for 20 min. The cells were washed in DB, resuspended at 1 × 10 8 cells ml −1 and lysed in an equal volume of ice-cold 2×lysis buffer (2% NP-40, 300 mM NaCl, 20 mM sodium phosphate (pH 7.0), protease inhibitors and phosphatase inhibitors) on ice for 10 min. The cell lysates were clarified by centrifugation at 4 °C and incubated with GFP-Trap agarose beads at 4 °C for 2 h to immunoprecipitate the GFP-RacE proteins. After washing with 1×lysis buffer, the bound fractions were eluted with 2×SDS-PAGE sample buffer and analysed by SDS-PAGE and immunoblotting using the appropriate antibodies. To analyse the protein-protein interactions in HEK293T cells, HEK293T cells plated on a 6-cm dish were transfected with different YFP-RhoA and YFP-Rac1 plasmids, cultured overnight and lysed in 0.25 ml 1×lysis buffer (150 mM NaCl, 0.5% NP-40, 10% glycerol, 1 mM EDTA, 20 mM Tris (pH 7.5), protease inhibitors and phosphatase inhibitors). The YFP-RhoA and YFP-Rac1 proteins were immunoprecipitated using GFP-Trap agarose beads.
Chemoattractant-induced AKT phosphorylation in cells. Differentiated Dictyostelium cells were incubated for 20 min at 22 °C in DB with 2 mM caffeine, washed twice with ice-cold DB and resuspended at 5 × 10 7 cells ml −1
. The cells were shaken at 200 r.p.m. at 22 °C and stimulated with 1 μM cAMP 39 . Aliquots were taken at different time points and lysed in SDS-PAGE sample buffer. Proteins were analysed by immunoblotting with antibodies to PKBA and PKBR1. Similar to what has been extensively described in many studies 23 , phosphorylation of PKBA and PKBR1 was detected using anti-phospho-RPS6KB1 antibodies (Cell Signaling, cat. no. 9205) and anti-phospho-PKC antibodies (Cell Signaling, cat. no. 2060) because of the similar amino acid sequences around the phosphorylation sites ( Supplementary Fig. 4 ).
Immunoblotting. Proteins were separated using SDS-PAGE and transferred onto PVDF membranes. The antibodies used were to: GFP 31, 59 , FLAG (Sigma, F7425 and F3165), PiaA 36 , Tor (Cell Signaling, cat. no. 2983), Rictor (Cell Signaling, cat. no. 2114), Raptor (Cell Signaling, cat. no. 2280), GAPDH (Thermo Fisher, MA5-15738), actin (Santa Cruz, Sc-1615), GSK-3 (Millipore, cat. no. 05-412), phospho-RPS6KB1 (Cell Signaling, cat. no. 9205), phospho-PKC (Cell Signaling, cat. no. 2060), AKT (Cell Signaling, cat. no. 9272) and phospho-AKT(S473; Cell Signaling, cat. no. 9271). Polyclonal rabbit antibodies to PKBA and PKBR1 were raised against the peptides KNSDRKKRVNG and KKGNKNDETTP, respectively. Polyclonal rabbit antibodies to RacE and phospho-RacE(S192) were raised against the peptide REQQHPDPNSGKF and the phosphopeptide GMDKK(pS) QDGSS. Immunocomplexes were visualized using fluorescently labelled secondary antibodies and detected using a Bio-Rad PharosFX Plus molecular imager. Images were analysed using NIH ImageJ. The detailed information on the antibodies used in this study is provided in Supplementary Table 4 .
Protein purification. Dictyostelium cells carrying the epitope-tagged proteins were differentiated, washed twice with ice-cold DB and resuspended at 1 × 10 8 cells ml
. To purify mTORC2 using FLAG-Tor, the cells were lysed in an equal volume of ice-cold 2×CHAPS lysis buffer (0.6% CHAPS, 250 mM NaCl, 2 mM EDTA, 100 mM HEPES (pH 7.4), protease inhibitors and phosphatase inhibitors) for 10 min on ice. After clarification by centrifugation, 1-ml volumes of the cell lysates were incubated with 15 µl anti-FLAG agarose beads for 2 h at 4 °C with gentle agitation to immunoprecipitate the proteins. The beads were washed using 1×CHAPS lysis buffer, snap frozen in liquid nitrogen and stored at −80 °C. In the experiments described in Fig. 6b ,c, in which individual subunits of mTORC2 were tested for AKT phosphorylation in vitro, FLAG-PiaA and FLAG-Lst8 were purified as described above and then washed twice in high-salt conditions (500 mM NaCl and 50 mM HEPES (pH 7.4)).
To purify FLAG-or GFP-RacE and FLAG-or GFP-RasC/G, cells at 1 × 10 8 cells ml −1 were lysed in an equal volume of ice-cold 2×NP-40 lysis buffer (2% NP-40, 250 mM NaCl, 2 mM EDTA, 10 mM sodium phosphate (pH 7.0), protease inhibitors and phosphatase inhibitors) for 10 min on ice. After clarification, 1-ml volumes of the cell lysates were incubated with 15 µl GFP-Trap or anti-FLAG agarose beads for 2 h at 4 °C with gentle agitation to immunoprecipitate the proteins. The beads were washed three times in 1×NP-40 lysis buffer, twice in high-salt wash buffer (500 mM NaCl and 10 mM sodium phosphate (pH 7.0)) and three times in 1×NP-40 lysis buffer. The washed beads were snap frozen in liquid nitrogen and stored at −80 °C.
In vitro phosphorylation of RacE by GSK-3β. Purified FLAG-RacE (40 ng) and GSK-3β (50 ng; Sigma, G4296) were mixed in 40 µl kinase reaction buffer 1 (10 mM MgCl 2 , 0.1% 2-mercaptoethanol and 50 mM Tris-HCl (pH 7.5)) for 15 min at room temperature in the presence or absence of 100 µM ATP. Phosphorylation of RacE at S192 was analysed by immunoblotting with antibodies to RacE and phosphoRacE(S192).
Reconstitution of chemoattractant-stimulated mTORC2-mediated AKT phosphorylation. The kinase activity of mTORC2 was measured as described previously 43, 44 with some modifications. RacE, RasC, RasG and mTORC2 were eluted from anti-FLAG beads by incubation with 1 M arginine at room temperature for 5 min (ref. 60 ). The purified proteins were quantified on CBBstained SDS-PAGE gels using ImageJ software with BSA as a standard. Purified mTORC2 (200 ng FLAG-Tor) was incubated with 40 ng RacE, 40 ng RasC/G and 40 ng inactive human AKT1 (Sigma, cat. no. 14-279) in 80 µl kinase reaction buffer 2 (1 mM ATP, 1 mM MgCl 2 , 100 mM potassium acetate and 25 mM HEPES (pH 7.4)) at room temperature for 5 min with gentle mixing. The reactions were stopped by adding 80 µl 2×SDS-PAGE sample buffer. AKT phosphorylation was detected by immunoblotting with anti-phospho-AKT(S473) antibodies (Cell Signaling, cat. no. 9271).
In vitro protein-protein interaction assay. To analyse the interactions between RacE, RasC/G and Tor, purified proteins were high-salt washed with 500 mM NaCl and 50 mM HEPES (pH 7.4). To examine the interactions of RacE with RasC/G and Tor, GFP-Trap carrying GFP-RacE (40 ng) was incubated with FLAG-RasC proteins (40 ng) and/or FLAG-Tor (200 ng) in kinase reaction buffer 2 without ATP at room temperature for 15 min. The GFP-Trap beads were washed three times in the same buffer and the bound proteins were analysed by immunoblotting. To examine the interactions of RasC/G with RacE and Tor, GFP-Trap beads carrying Ras proteins (40 ng) were incubated with FLAG-tagged RacE (40 ng) and Tor (200 ng).
Statistics and reproducibility. Unpaired, two-tailed Student's t-tests were performed using GraphPad Prism7 to determine the statistical significance of the experiments described in Supplementary Fig. 2 . For the multiple group comparisons, one-way ANOVA analysis followed by a Tukey's test was performed using Prism7 (Figs. 1b,e, 2b,d and 5f,h) . The statistical analyses and P values are described in each figure and figure legend. The number of independent experiments performed is described in each figure legend.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
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nature research | reporting summary
October 2018
Corresponding author(s): Miho Iijima Last updated by author(s): May 18, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
Unprocessed images of all blots and gels are provided as Supplementary Figure 8 . Source data for mass spectrometry are provided in Supplementary Tables 1 and 2 . Source data for all graphical representations and statistical descriptions are provided in Supplementary Table 4 . All other data supporting the findings of this study are available from the corresponding author on reasonable request.
